Showing results (71-80 of 447) with videos related to
Sort By:
Pageof 45
Cardio-Oncology (London, England)|May 29, 2021
Evidence-based prediction and prevention of cardiovascular morbidity in adults treated for cancerRenske Altena, Laila Hubbert, Narsis A Kiani, et al.Cardio-Oncology (London, England)|May 29, 2021
A retrospective analysis of cardiovascular adverse events associated with immune checkpoint inhibitorsJessica Castrillon Lal, Sherry-Ann Brown, Patrick Collier, et al.Cardio-Oncology (London, England)|May 18, 2023
Quantitative assessment of radiotherapy-induced myocardial damage using MRI: a systematic reviewAlireza Omidi, Elisabeth Weiss, Cory R Trankle, et al.Cardio-Oncology (London, England)|May 19, 2023
Development of cardiac risk prediction model in patients with HER-2 positive breast cancer on trastuzumab therapyPrince Otchere, Olusola Adekoya, Samuel B Governor, et al.Cardio-Oncology (London, England)|March 14, 2023
Clinicopathological classification of immune checkpoint inhibitor-associated myocarditis: possible refinement by measuring macrophage abundanceJesus Jimenez, Nicolas Kostelecky, Joshua D Mitchell, et al.Cardio-Oncology (London, England)|August 24, 2021
Rationale and proposed framework for shared decision making in cardio-oncologySarah C Hull, Aaron Soufer, Erica S Spatz, et al.Cardio-Oncology (London, England)|March 27, 2023
Anthracycline cardiotoxicity: current methods of diagnosis and possible role of 18F-FDG PET/CT as a new biomarkerMônica M C Becker, Gustavo F A Arruda, Diego R F Berenguer, et al.Cardio-Oncology (London, England)|December 16, 2025
Redefining cardiac risk in breast radiotherapy: a substructure-based dosimetric and biomarker correlation studyRishi P Nair, Depanshu Aggarwal, Atul Gupta, et al.Cardio-Oncology (London, England)|November 26, 2025
CPX-351 vs. conventional chemotherapy cardiotoxicity in high-risk AML: a post hoc phase III trial analysisJoshua D Mitchell, Michael Pfeiffer, John Boehmer, et al.Cardio-Oncology (London, England)|November 18, 2025
How should immune checkpoint inhibitor myocarditis be treated?Sally Badaan, Adi Abbass, Svetlana Tov, et al.Pageof 45